Ionis Pharmaceuticals Inc (NASDAQ:IONS)
| 61.30 Delayed Data As of 3:59pm ET |  -0.06 / -0.10%Today’s Change | 39.32 Today|||52-Week Range 64.26 | +8.42% Year-to-Date |
Latest IONS News | Press Releases
No recent news for Ionis Pharmaceuticals Inc.
Today’s Trading
| Previous close | 61.36 |
| Today’s open | 61.35 |
| Day’s range | 61.35 - 63.20 |
| Volume | 43,187 |
| Average volume (3 months) | 1,134,757 |
| Market cap | $8.1B |
Data as of 3:59pm ET, 01/15/2021
Growth & Valuation
| Earnings growth (last year) | +1.24% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | +29.26% |
| Revenue growth (last year) | +87.20% |
| P/E ratio | 125.1 |
| Price/Sales | 7.69 |
| Price/Book | 5.49 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ACADACADIA Pharmaceutica... | -0.80 | -1.47% |
| RAREUltragenyx Pharmaceu... | -2.10 | -1.50% |
| JAZZJazz Pharmaceuticals... | +1.62 | +0.98% |
| BHCValeant Pharmaceutic... | -0.04 | -0.15% |
Data as of 4:00pm ET, 01/15/2021
Financials
| Next reporting date | March 2, 2021 |
| EPS forecast (this quarter) | $0.27 |
| Annual revenue (last year) | $1.1B |
| Annual profit (last year) | $296.6M |
| Net profit margin | 26.42% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Carlsbad, California |
Forecasts
